Is coronary artery disease a multifactorial inherited disorder with a sex-influenced trait?

Medical Hypotheses

Volumn 71, Issue 3, 2008, Pages 449-452

  Yang, Changsheng ^a   Wang, Xiaoping ^b   Ding, Hongliu ^c  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYOCYTE ENHANCER FACTOR 2; SEX HORMONE;

ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; AUTOSOMAL RECESSIVE INHERITANCE; CORONARY ARTERY DISEASE; GENE INTERACTION; GENETIC MODEL; HORMONE SUBSTITUTION; HUMAN; INCIDENCE; MULTIFACTORIAL INHERITANCE; PEDIGREE ANALYSIS; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; SEX RATIO; X CHROMOSOME;

CORONARY ARTERY DISEASE; FEMALE; GENES, DOMINANT; GONADAL STEROID HORMONES; HUMANS; MALE; MODELS, GENETIC; MULTIFACTORIAL INHERITANCE; SEX FACTORS;

EID: 47549092746     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2008.02.019     Document Type: Article

References (42)

1. US Department of Health and Human Services, National Heart, Lung, and Blood Institute. Report of the task force on research in epidemiology and prevention of cardiovascular diseases. National Institutes of Health: August; 1994.
2. Keys A. Seven countries: a multivariate analysis of death and coronary heart disease. Cambridge, Mass, and London, UK: Harvard University Press; 1980.
3. The Pooling Project Research Group. Relationship of blood pressure, serum cholesterol, smoking habit, relative weight, and ECG abnormalities to incidence of major coronary events: final report of the pooling project. Dallas, Tex: American Heart Association Monograph No. 60; 1978.
4. Neaton J.D., Blackburn H., Jacobs D., Kuller L., Lee D.J., Sherwin R., et al. Serum cholesterol level and mortality findings for men screened in the multiple risk factor intervention trial multiple risk factor intervention trial research group. Arch Int Med 152 7 (1992) 1490-1500
5. NIH consensus conference. Triglyceride, high-density lipoprotein, and coronary heart disease NIH consensus development panel on triglyceride, high-density lipoprotein, and coronary heart disease. JAMA 1993;269(4):505-10.
6. Corrao J.M., Becker R.C., Ockene I.S., and Hamilton G.A. Coronary heart disease risk factors in women. Cardiology 77 Suppl. 2 (1990) 8-24
7. Jacobs Jr. D.R., Mebane I.L., Bangdiwala S.I., Criqui M.H., and Tyroler H.A. High-density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: the follow-up study of the lipid research clinics prevalence study. Am J Epidemiol 131 1 (1990) 32-47
8. Willett W.C., Green A., Stampfer M.J., Speizer F.E., Colditz G.A., Rosner B., et al. Relative and absolute excess risks of coronary heart disease among women who smoke cigarettes. N Engl J Med 317 21 (1987) 1303-1309
9. Manson J.E., Colditz G.A., Stampfer M.J., Willett W.C., Rosner B., Monson R.R., et al. A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med 322 13 (1990) 882-889
10. Head J., and Fuller J.H. International variations in mortality among diabetic patients: the WHO multinational study of vascular disease in diabetics. Diabetologia 33 8 (1990) 477-481
11. Jousilahti P., Tuomilehto J., Vartiainen E., Pekkanen J., and Puska P. Body weight, cardiovascular risk factors, and coronary mortality. 15-Year follow-up of middle-aged men and women in eastern Finland. Circulation 93 7 (1996) 1372-1379
12. Jackson R., Chambless L., Higgins M., Kuulasmaa K., Wijnberg L., and Williams D. Sex difference in ischaemic heart disease mortality and risk factors in 46 communities: an ecologic analysis. Cardiovasc Risk Fact 7 (1997) 43-54 [WHO MONICA Project, and ARIC Study]
13. Johnson A. Sex differentials in coronary heart disease: the explanatory role of primary risk factors. J Health Soc Behav 18 (1977) 46-54
14. Larsson B., Bengtsson C., Bjorntorp P., Lapidus L., Sjostrom L., Svardsudd K., et al. Is abdominal body fat distribution a major explanation for the sex difference in the incidence of myocardial infarction? The study of men born in 1913 and the study of women, Goteborg, Sweden. Am J Epidemiol 135 3 (1992) 266-273
15. Thelle D. Women and coronary heart disease: a review with special emphasis on some risk factors. Lipid Rev 4 (1990) 33-39
16. Thom TJ, Epstein FH, Feldman JJ, Leaverton PE, Wolz M. Total mortality and mortality from heart disease, cancer and stroke from 1950 to 1987 in 27 countries. Bethesda, Md: National Institutes of Health, NIH publication: 1992. p. 92-3088.
17. Castelli W.P. Epidemiology of coronary heart disease: the Framingham study. Am J Med 76 2A (1984) 4-12
18. Kuhn F.E., and Rackley C.E. Coronary artery disease in women. Risk factors, evaluation, treatment, and prevention. Arch Int Med 153 23 (1993) 2626-2636
19. Tunstall-Pedoe H., Kuulasmaa K., Amouyel P., Arveiler D., Rajakangas A.M., and Pajak A. Myocardial infarction and coronary deaths in the world health organization MONICA project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 90 1 (1994) 583-612
20. Njolstad I., Arnesen E., and Lund-Larsen P.G. Smoking, serum lipids, blood pressure, and sex differences in myocardial infarction a 12-year follow-up of the finnmark study. Circulation 93 3 (1996) 450-456
21. Rich-Edwards J.W., Manson J.E., Hennekens C.H., and Buring J.E. The primary prevention of coronary heart disease in women. N Engl J Med 332 26 (1995) 1758-1766
22. Rosamond W., Flegal K., Friday G., Furie K., Go A., Greenlund K., et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics -- 2007 update: a report from the American heart association statistics committee and stroke statistics subcommittee. Circulation 115 5 (2007) e69-e171
23. Reardon M.F., Nestel P.J., Craig I.H., and Harper R.W. Lipoprotein predictors of the severity of coronary artery disease in men and women. Circulation 71 5 (1985) 881-888
24. Jensen J., Nilas L., and Christiansen C. Influence of menopause on serum lipids and lipoproteins. Maturitas 12 4 (1990) 321-331
25. Knopp R.H., Zhu X., and Bonet B. Effects of estrogens on lipoprotein metabolism and cardiovascular disease in women. Atherosclerosis 110 Suppl. (1994) S83-S91
26. Applebaum-Bowden D., McLean P., Steinmetz A., Fontana D., Matthys C., Warnick G.R., et al. Lipoprotein, apolipoprotein, and lipolytic enzyme changes following estrogen administration in postmenopausal women. J Lipid Res 30 12 (1989) 1895-1906
27. Ridker P.M., Hennekens C.H., Rifai N., Buring J.E., and Manson J.E. Hormone replacement therapy and increased plasma concentration of C-reactive protein. Circulation 100 7 (1999) 713-716
28. Cushman M., Legault C., Barrett-Connor E., Stefanick M.L., Kessler C., Judd H.L., et al. Effect of postmenopausal hormones on inflammation-sensitive proteins: the postmenopausal estrogen/progestin interventions (PEPI) study. Circulation 100 7 (1999) 717-722
29. Wilson P.W. Established risk factors and coronary-artery disease: the Framingham study. Am J Hypertens 7 7 Pt 2 (1994) 7S-12S
30. Knopp R.H., Zhu X., Bonet B., and Bagatell C. Effects of sex steroid hormones on lipoproteins, clotting, and the arterial wall. Semin Reprod Endocrinol 14 1 (1996) 15-27
31. Hulley S., Grady D., Bush T., Furberg C., Herrington D., Riggs B., et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and estrogen/progestin replacement study (HERS) research group. JAMA 280 7 (1998) 605-613
32. Herrington D.M., Reboussin D.M., Brosnihan K.B., Sharp P.C., Shumaker S.A., Snyder T.E., et al. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. N Engl J Med 343 8 (2000) 522-529
33. Rossouw J.E., Anderson G.L., Prentice R.L., LaCroix A.Z., Kooperberg C., Stefanick M.L., et al. Writing group for the women's health initiative investigators. risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. JAMA 288 3 (2002) 321-333
34. Hawe E., Talmud P.J., Miller G.J., and Humphries S.E. Second Northwick park heart study. Family history is a coronary heart disease risk factor in the second Northwick park heart. Ann Hum Genet 67 Pt 2 (2003) 97-106
35. Marenberg M.E., Risch N., Berkman L.F., Floderus B., and de Faire U. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 330 15 (1994) 1041-1046
36. Mayer B., Erdmann J., and Schunkert H. Genetics and heritability of coronary-artery disease and myocardial infarction. Clin Res Cardiol 96 1 (2007) 1-7
37. Brown M.S., Kovanen P.T., and Goldstein J.L. Regulation of plasma cholesterol by lipoprotein receptors. Science 212 4495 (1981) 628-635
38. Wang L., Fan C., Topol S.E., Topol E.J., and Wang Q. Mutation of MEF2A in an inherited disorder with features of coronary-artery disease. Science 302 5650 (2003) 1578-1581
39. Samani N.J., Erdmann J., Hall A.S., Hengstenberg C., Mangino M., Mayer B., et al. WTCCC and the cardiogenics consortium. Genomewide association analysis of coronary-artery disease. N Engl J Med 357 5 (2007) 443-453
40. Pajukanta P., Cargill M., Viitanen L., Nuotio I., Kareinen A., Perola M., et al. Two loci on chromosomes 2 and X for premature coronary heart disease identified in early- and late-settlement populations of Finland. Am J Hum Genet 67 6 (2000) 1481-1493
41. Bonnardeaux A., Davies E., Jeunemaitre X., Fery I., Charru A., Clauser E., et al. Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension 24 1 (1994) 63-69
42. Tiret L., Bonnardeaux A., Poirier O., Ricard S., Marques-Vidal P., Evans A., et al. Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet 344 8927 (1994) 910-913